PUBLIC CONTRACT · 2022
AD 78-22 Aquisição do Medicamento USTECINUMAB [130 MG; SOL INJ; FRS]
- Contract value
- €6,024.24
- Signed on
- 22 November 2022
- Procedure
- Ao abrigo de acordo-quadro (art.º 258.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 9577046PUBLISHED DESCRIPTION
AD 78/2022
Parties involved
- Place of performance
- Portugal, Castelo Branco, Covilhã
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- Janssen-Cilag Farmacêutica, Lda · Tax ID 500189412
Values and timeline
- Contract price
- €6,024.24
- Procedure base price
- €6,024.24
- Total effective price
- €6,024.24
- Publication date
- 23 November 2022
- Award date
- 18 November 2022
- Signing date
- 22 November 2022
- Performance period
- 61 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 258.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 258.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- CP 2021/6 - Medicamentos do foro oncológico e imunomoduladores
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 6137387
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.